Better Sooner More Convenient Primary Care - New Zealand Doctor
Better Sooner More Convenient Primary Care - New Zealand Doctor
Better Sooner More Convenient Primary Care - New Zealand Doctor
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
8 Effect on inequalities<br />
It is anticipated that more effective and efficient clinical pathways in both laboratory referred<br />
services and pharmacy services will lead to a reduction in resource wastage (both time and<br />
money) enabling more attention and resources to identify and target those most in need in order<br />
meet their health needs in a better sooner more convenient way.<br />
9 Evidence for this initiative<br />
In 2009 West Coast <strong>Primary</strong> Health Organisation commissioned a report 51 to investigate ways in<br />
which the PHO could, and community pharmacies would, work together more closely to advance<br />
its goal of achieving better health for people on the West Coast. This report identified the<br />
following from evidence in the literature:<br />
“Medication has the ability to enhance the quality of life and reduce the manifestations<br />
of diseases that would normally lead to suffering and premature death. There is also a<br />
growing awareness of the potential for these same drugs to cause a significant amount<br />
of morbidity and mortality.<br />
Underpinning nearly all innovative, cognitive services that might be provided by<br />
pharmacists is the issue of drug-related morbidity and mortality. Drug-related<br />
morbidity and mortality represents a serious medical problem that requires expert<br />
interdisciplinary attention. Unrecognised and unresolved drug therapy problems may<br />
result in extra primary care visits, hospitalisations, long term care facility admissions<br />
and premature death. The literature suggests that a large proportion of drug-related<br />
morbidity is preventable. Potentially pharmacists have the skills to ameliorate this<br />
problem by identifying existing and potential drug therapy problems likely to cause<br />
harm, a reduction in the quality of life, or death. “<br />
It went on to say that:<br />
“Clinical advisory pharmacists are recognised as having the qualifications, skills and<br />
abilities to work in a variety of specialist roles. The services provided focus on<br />
optimising medicines-related health outcomes for individual patients and working to<br />
reduce existing and potential drug therapy problems from a population based health<br />
perspective,<br />
These roles may include:<br />
• Pharmacist facilitation<br />
• Comprehensive medication management (clinical medication reviews)<br />
• Medicines therapy assessment (eg. in rest homes, residential care)<br />
51 Linda Bryant and John Dunlop. Opening the Door on Community Pharmacy, , June 2009)<br />
Business case appendices V12 AC 25Feb2010 Page 84